The role of SSA at progression - to continue or not?
This podcast explores therapeutic decision making for patients at progression for people living
with NETs. The experts analyse data from prospective studies NETTER-1, CLARINET FORTE and REMINET.
Prof. Martyn Caplin UK
Dr. Aman Chauhan US
PODCAST | 30 MIN | CME Credit
PODCAST | 30 MIN
Systemic therapy in endometrial carcinoma: the nurses' perspective
Experts in gynae-oncology nursing provide insights on treatment with systemic therapies and how to
navigate side effects.
Lead
Nurse Andreia Fernandes UK
Clinical Nurse Jo Pearson UK
PODCAST | 30 MIN
PODCAST | 20 MIN
Clinical implementation of targeted and immunotherapies for advanced RCC
The experts discuss the use of targeted and immunotherapies in the therapeutic strategy for
advanced RCC patients and the importance of managing toxicities through dose modification and
education.
Prof.
Thomas Powles UK
Dr Friederike Schlürmann France
PODCAST | 20 MIN
PODCAST | 24 MIN
Shared decision-making in nmCRPC
This podcast gives both nurse and physician views on the importance of shared decision-making for
nmCRPC patients and key considerations for treatment selection including adverse event management
and drug interactions.
Dr.
Alicia Morgans US
Nurse Brenda Martone US
PODCAST | 24 MIN
Learn of Other Programmes in Oncology
EXPERT VIEW | 9 MIN
Optimising treatment sequencing for mCRC, third line and beyond
How can oncology practitioners optimise treatment sequencing for patients with metastatic
colorectal cancer (mCRC), third line and beyond?
Prof. Sebastian Stintzing Germany
Dr. Juan Manuel O'Connor Argentina
EXPERT VIEW | 9 MIN
Optimising treatment sequencing for mCRC, third line and beyond
How can oncology practitioners optimise treatment sequencing for patients with metastatic
colorectal cancer (mCRC), third line and beyond?
Prof. Sebastian Stintzing Germany
Dr. Juan Manuel O'Connor Argentina
KEY
PUBLICATION | 4 MIN
Publication Snapshot: Regorafenib for the Treatment of Sarcoma
Listen as Professor Robert Maki discusses regorafenib as a potential therapy in sarcoma in this
review of clinical trials.
Prof. Robert Maki US
KEY
PUBLICATION | 4 MIN
Publication Snapshot: Regorafenib for the Treatment of Sarcoma
Listen as Professor Robert Maki discusses regorafenib as a potential therapy in sarcoma in this
review of clinical trials.
Prof. Robert Maki US
This email is from COR2ED as a provider of independent and medical education and not in the
pursuit of any commercial interest. You receive this email as a healthcare professional with
expertise In one or more topics covered by COR2ED's educational programmes, to help inform your
clinical practice with the aim of improving the overall health of patients. The material and
content contained and accessed via this newsletter are for healthcare professionals only. By
visiting our websites you acknowledge COR2ED's Privacy Policy. Although every effort is made to
ensure that the material within this newsletter is accurate and timely, it is provided for
informational and educational purposes only. The information provided via this newsletter is not a
substitute for medical professional help, advice, diagnosis or treatment and may not be applicable
to every case or country. The views are the personal opinions of the experts. They do not
necessarily represent the views of the expert's academic institution, employer, organisation, or
other group or individual.
You receive this email as a healthcare professional with expertise and knowledge in this topic or
therapeutic area. If you wish to unsubscribe from entails of this type, please feel free to
unsubscribe below.
Oncology
Podcast Digest
PODCAST | 
30 MIN | 
CME Credit
Prof. Martyn Caplin 
Dr. Aman Chauhan 
Lead
Nurse Andreia Fernandes 
Clinical Nurse Jo Pearson 
Prof.
Thomas Powles 
Dr Friederike Schlürmann 
Dr.
Alicia Morgans 
Nurse Brenda Martone 
Prof. Sebastian Stintzing 
Dr. Juan Manuel O'Connor 
Prof. Robert Maki 
